Low Dose Naltrexone
Low Dose Naltrexone is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Low Dose Naltrexone Use in Patients With POTS
Low Dose Naltrexone for Pain in Patients With HIV
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Clinical Trials (10)
Low Dose Naltrexone Use in Patients With POTS
Low Dose Naltrexone for Pain in Patients With HIV
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Low Dose Naltrexone (LDN) Immune Monitoring
Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome
Effects of Low Dose Naltrexone in Fibromyalgia
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10